Learn More
Medchemexpress LLC XY028-133 | 2229974-73-4 | 98.6% | 25 MG

Supplier: Medchemexpress LLC 25MGHY129180
XY028-133 is a PROTAC-based degrader targeting CDK4/6, exhibiting anti-tumor activity by consisting of ligands for von Hippel-Lindau and cyclin-dependent kinase. It significantly reduces levels of key cell cycle proteins.
- PROTAC-based degrader
- Exhibits anti-tumor activity
- Consists of ligands for von Hippel-Lindau and cyclin-dependent kinase
- Decreases CDK4/6 protein levels
- Decreases Cyclin A, PLK1, and pRb protein levels
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.